Viewing Study NCT02790320


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-03-02 @ 11:09 PM
Study NCT ID: NCT02790320
Status: COMPLETED
Last Update Posted: 2016-06-03
First Post: 2016-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer
Sponsor:
Organization: